CRVL · CorVel Corp
Price
Snapshot
50 fields · last close| Market Cap | $3.76B |
| P/E | 32.12 |
| Float | 31.13M |
| Beta | 1.10 |
| Volatility | 27.5% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | Moderate |
| Clavix score | 76.2 |
| Price | 74.67 |
| Change | +0.27% |
| Prev Close | 74.47 |
| Open | 73.38 |
| Day Low | 73.33 |
| Day High | 74.49 |
| Avg Vol | 0 |
| Avg $ Vol | $16.80M |
| 52W High | 79.43 |
| 52W Low | 44.83 |
| 52W Pos | 86.2% |
| From High | −5.99% |
| From Low | +66.56% |
| Max DD 1Y | −40.68% |
| Spread | 0.10% |
| Liquidity | Thin |
| SMA 20 | +5.21% |
| SMA 50 | +11.48% |
| SMA 200 | +21.78% |
| RSI (14) | 67.6 |
| Vol 30D | 26.5% |
| Vol 90D | 33.2% |
| 1Y Range | 45–79 |
| Daily bars | 275 |
| Perf Week | +1.20% |
| Perf Month | +7.55% |
| Perf Quarter | +19.11% |
| Perf Half Y | +37.35% |
| Perf Year | −5.30% |
| Perf YTD | +13.58% |
| Prev Day | +0.27% |
| Clavix | B+ |
| Debt / Eq | 0.00 |
| Curr Ratio | 2.03 |
| Int Cover | 17.3× |
| FCF Margin | 11.8% |
| Rev Growth | +10.7% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 25 / 49 |
Clavix risk grade
regraded every trading dayCRVL grades B+, 76.2 of 100. Steadiest on Sector Resilience (71), most exposed on Price Stability (59, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 25 of 49 in Health Care by Clavix score.
How rough the ride is
| CRVL | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.10 | 0.85 |
| Volatilityannualized | 27.5% | 21.2% |
| Max drawdown, past yearworst peak-to-trough fall | −40.7% | — |
| Typical daily movemedian absolute daily change | 1.15% | — |
| Days beyond ±3%of the last 252 sessions | 3313% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| CRVL | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.10 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate57% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| CRVL | |
|---|---|
| 1 week | +1.2% |
| 1 month | +7.6% |
| Year to date | +13.6% |
| 1 year | −5.3% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| CRVL | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 8since 5 Aug |
| Average score0 most bearish, 100 most bullish | 69 |
| Bullish · bearisharticles above 60 · below 40 | 7 · 1 |
| Directionarticles whose tone is improving vs worsening | 7 ↑ 1 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| CRVL | |
|---|---|
| Revenue growthyear over year | +10.7% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openCorVel reported fiscal 2026 revenue of roughly $959 million, funded by a debt-free balance sheet with hundreds of millions in cash. On September 22, the company announced that insurance carriers using Guidewire's ClaimCenter software can now start and manage CorVel's managed care services directly from within their claims screen, without switching systems.
CorVel launched CareMC Accelerator for Guidewire ClaimCenter, a tool that lets insurance carriers start and manage managed care services directly inside their claims system using a single login and shared data feeds.
CorVel launched its CareMC Accelerator for Guidewire ClaimCenter, a connector that links CorVel's managed care platform to Guidewire's claims-handling software used by insurers. The product is designed to let data move between the two systems in real time and cut down on manual work.
CorVel and its sales training partner ASLAN Training & Development won Gold in the Best Program for Sales Training & Performance category at the 2026 Brandon Hall Group HCM Excellence Awards, recognizing their multiyear partnership built on ASLAN's Other-Centered Selling methodology.
CorVel director R Judd Jessup sold 1,262 shares on August 27th at an average price of $70.64, collecting about $89,148 in total. After the sale, he still directly held 115,821 shares worth roughly $8.18 million, and the sale was filed with the SEC.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company Inc | C+ | $2.61B | — | 0.65 | Compare |
| RDNT | RadNet Inc | B | $5.56B | — | 1.45 | Compare |
| BFLY | Butterfly Network Inc | F | $2.47B | — | 2.15 | Compare |
| HIMS | Hims & Hers Health Inc | D- | $6.70B | 52.16 | 2.54 | Compare |
| HNGE | Hinge Health Inc | C+ | $7.68B | 68.40 | 1.59 | Compare |
| PODD | Insulet Corp | C+ | $9.21B | 24.41 | 1.09 | Compare |
| GKOS | Glaukos Corp | B- | $9.35B | — | 0.74 | Compare |
| HSIC | Henry Schein Inc | A- | $9.47B | 23.52 | 0.87 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.